
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10656142
[patent_doc_number] => 20160002286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/859983
[patent_app_country] => US
[patent_app_date] => 2015-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12802
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/859983 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | Sep 20, 2015 | Abandoned |
Array
(
[id] => 10979982
[patent_doc_number] => 20160176926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1'
[patent_app_type] => utility
[patent_app_number] => 14/860381
[patent_app_country] => US
[patent_app_date] => 2015-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 23395
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14860381
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/860381 | PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1 | Sep 20, 2015 | Abandoned |
Array
(
[id] => 10489642
[patent_doc_number] => 20150374663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'Compositions and Methods for Controlled Localized Delivery of Bone Forming Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 14/853772
[patent_app_country] => US
[patent_app_date] => 2015-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 37927
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14853772
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/853772 | Compositions and methods for controlled localized delivery of bone forming therapeutic agents | Sep 13, 2015 | Issued |
Array
(
[id] => 10805298
[patent_doc_number] => 20160151455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 14/851622
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22708
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851622
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851622 | Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use | Sep 10, 2015 | Abandoned |
Array
(
[id] => 10805298
[patent_doc_number] => 20160151455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use'
[patent_app_type] => utility
[patent_app_number] => 14/851622
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22708
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851622
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851622 | Synthetic Apolipoprotein E Mimicking Polypeptides And Methods Of Use | Sep 10, 2015 | Abandoned |
Array
(
[id] => 10654808
[patent_doc_number] => 20160000952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Targeted Enzymatic Degradation Of Quorum-Sensing Peptides'
[patent_app_type] => utility
[patent_app_number] => 14/851178
[patent_app_country] => US
[patent_app_date] => 2015-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8387
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14851178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/851178 | Targeted enzymatic degradation of quorum-sensing peptides | Sep 10, 2015 | Issued |
Array
(
[id] => 11936448
[patent_doc_number] => 20170240599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'A PROCESS FOR THE PREPARATION OF LINACLOTIDE'
[patent_app_type] => utility
[patent_app_number] => 15/508928
[patent_app_country] => US
[patent_app_date] => 2015-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4424
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508928
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508928 | Process for the preparation of linaclotide | Aug 28, 2015 | Issued |
Array
(
[id] => 10712558
[patent_doc_number] => 20160058705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES AND DISORDERS WITH APELIN'
[patent_app_type] => utility
[patent_app_number] => 14/838942
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 19036
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838942
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838942 | COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR AND PULMONARY DISEASES AND DISORDERS WITH APELIN | Aug 27, 2015 | Abandoned |
Array
(
[id] => 13065455
[patent_doc_number] => 10053500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-21
[patent_title] => Variant of antihemophilic factor VIII having increased specific activity
[patent_app_type] => utility
[patent_app_number] => 14/834769
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8234
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834769
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834769 | Variant of antihemophilic factor VIII having increased specific activity | Aug 24, 2015 | Issued |
Array
(
[id] => 15225171
[patent_doc_number] => 10500290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer
[patent_app_type] => utility
[patent_app_number] => 15/505846
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15188
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505846 | Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer | Aug 20, 2015 | Issued |
Array
(
[id] => 10684179
[patent_doc_number] => 20160030324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'APPLICATIONS OF SURFACTIN IN EMULSIFYING COMPOSITION AND THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/830556
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9868
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830556
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/830556 | APPLICATIONS OF SURFACTIN IN EMULSIFYING COMPOSITION AND THEREOF | Aug 18, 2015 | Abandoned |
Array
(
[id] => 10700538
[patent_doc_number] => 20160046686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING TUMOR CELLS BY INHIBITING THE TRANSCRIPTION FACTOR ATF5'
[patent_app_type] => utility
[patent_app_number] => 14/830194
[patent_app_country] => US
[patent_app_date] => 2015-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 17710
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14830194
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/830194 | COMPOSITIONS AND METHODS FOR INHIBITING TUMOR CELLS BY INHIBITING THE TRANSCRIPTION FACTOR ATF5 | Aug 18, 2015 | Abandoned |
Array
(
[id] => 10700537
[patent_doc_number] => 20160046684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'Methods and compositions for treatment of PTP1B-related diseases'
[patent_app_type] => utility
[patent_app_number] => 14/826686
[patent_app_country] => US
[patent_app_date] => 2015-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 54
[patent_no_of_words] => 12959
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14826686
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/826686 | Methods and compositions for treatment of PTP1B-related diseases | Aug 13, 2015 | Abandoned |
Array
(
[id] => 10737275
[patent_doc_number] => 20160083425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Allosteric Binding Ligands To Modulate Serum Low Density Lipoprotein (LDL) Levels'
[patent_app_type] => utility
[patent_app_number] => 14/825700
[patent_app_country] => US
[patent_app_date] => 2015-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26364
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14825700
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/825700 | Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels | Aug 12, 2015 | Issued |
Array
(
[id] => 12302619
[patent_doc_number] => 09937228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Treatment of myocardial infarction by inhibiting the action of mAKAPb
[patent_app_type] => utility
[patent_app_number] => 14/821082
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 46
[patent_no_of_words] => 23403
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14821082
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/821082 | Treatment of myocardial infarction by inhibiting the action of mAKAPb | Aug 6, 2015 | Issued |
Array
(
[id] => 13220625
[patent_doc_number] => 10124073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-13
[patent_title] => Targeting peptides and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/502160
[patent_app_country] => US
[patent_app_date] => 2015-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 33
[patent_no_of_words] => 14066
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502160
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502160 | Targeting peptides and methods of use | Aug 3, 2015 | Issued |
Array
(
[id] => 10676686
[patent_doc_number] => 20160022832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'PROTEAS STABILIZED ANTIBACTERIAL PEPTIDES FOR S. AUREUS'
[patent_app_type] => utility
[patent_app_number] => 14/808984
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 1203
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14808984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/808984 | Proteas stabilized antibacterial peptides for S. aureus | Jul 23, 2015 | Issued |
Array
(
[id] => 10662337
[patent_doc_number] => 20160008481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'SELF-ASSEMBLING COMPLEX FOR TARGETING CHEMICAL AGENTS TO CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/796758
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 11544
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796758
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796758 | Self-assembling complex for targeting chemical agents to cells | Jul 9, 2015 | Issued |
Array
(
[id] => 12858214
[patent_doc_number] => 20180177912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => INJECTABLE BONE SUBSTITUTES FOR AUGMENTING IMPLANT FIXATION
[patent_app_type] => utility
[patent_app_number] => 15/324590
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/324590 | INJECTABLE BONE SUBSTITUTES FOR AUGMENTING IMPLANT FIXATION | Jul 6, 2015 | Abandoned |
Array
(
[id] => 12466389
[patent_doc_number] => 09987371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Compositions and methods for polynucleotide transfection
[patent_app_type] => utility
[patent_app_number] => 14/790408
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 91
[patent_figures_cnt] => 166
[patent_no_of_words] => 34226
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14790408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/790408 | Compositions and methods for polynucleotide transfection | Jul 1, 2015 | Issued |